Yuto Fujibayashi
Kyoto, 6028566, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications
The Rationale for the Dual-Targeting Therapy for RSK2 and AKT in Multiple Myeloma.
Journal: International journal of molecular sciences
Published: January 25, 2022
EWSR1 overexpression is a pro-oncogenic event in multiple myeloma.
Journal: International journal of hematology
Published: July 06, 2020
Lenalidomide and pomalidomide potently interfere with induction of myeloid-derived suppressor cells in multiple myeloma.
Journal: British journal of haematology
Published: February 22, 2020
Tumor-specific transcript variants of cyclin D1 in mantle cell lymphoma and multiple myeloma with chromosome 11q13 abnormalities.
Journal: Experimental hematology
Published: January 19, 2020
A novel method of amplified fluorescent in situ hybridization for detection of chromosomal microdeletions in B cell lymphoma.
Journal: International journal of hematology
Published: November 26, 2018
Dual targeting of bromodomain-containing 4 by AZD5153 and BCL2 by AZD4320 against B-cell lymphomas concomitantly overexpressing c-MYC and BCL2.
Journal: Investigational new drugs
Published: May 10, 2018
Establishment and Characteristics of a Novel Mantle Cell Lymphoma-derived Cell Line and a Bendamustine-resistant Subline.
Journal: Cancer genomics & proteomics
Published: February 19, 2018
Chromosomal abnormality variation detected by G-banding is associated with prognosis of diffuse large B-cell lymphoma treated by R-CHOP-based therapy.
Journal: Cancer medicine
Published: September 13, 2017
A chemical probe that labels human pluripotent stem cells.
Journal: Cell reports
Published: February 07, 2012
Showing 1-11 of 11
Last Updated: 09/26/2026